TMC Pharma Services is a global pharmaceutical developer.

Investment type
  • Management buyout


Quote mark

LDC’s relationship-focused approach, coupled with their sector knowledge and experience of supporting international growth strategies made them the perfect choice of partner to support TMC on the journey ahead.”

Julie Matthews, Co-Founder and Non-Executive Director
TMC Pharma Services

In May 2024, TMC announced the appointment of Simon Estcourt as Chief Executive Officer. Simon joined from Abacus Medicine Pharma Services, where he served as Managing Director. The appointment is part of the company’s long-term succession plan and Simon succeeds Julie Matthews, who will continue as a Non-Executive Director to support further expansion.

Together Caring for Rare Disease

TMC Pharma Services was part of a news-style programme produced by ITN Business to mark Rare Disease Day on 28 February. The programme, ‘Together Caring for Rare Disease’, has been produced in partnership with Genetic Alliance UK and covers the complexity and life-limiting impact of rare diseases, along with how technology, science, treatment and management can make a difference, and includes interviews with the TMC Pharma team about their work.